\
&
Contact us
\
&
Contact us
This was 3 years ago
Locationhybrid
Citizen science refers to activities conducted by scientists in collaboration or consultation with the public at any stage of a research project. By sharing lessons learnt and best practices within and across scientific domains, the following challenges faced by both scientists and citizens will be addressed:
Programme
9:00 – 9:10 Opening
9:10 – 10:00 Setting the scene: What is citizen science and why it matters?
10:00 – 10:20 Coffee/tea break
10:20 – 11:30 Sharing experiences: what methodologies, approaches, conditions work best to conduct citizen science? with contributions from among others the Starting grant project Lacto-Be and Proof of Concept grant project UnderSCORE
11:30 – 12:10 Harvesting session: does citizen science help pushing the frontiers of knowledge? Does frontier knowledge matter for citizens?
12:10 – 12:15 What’s next? by ERC
14:30 – 15:25 Young people engaged for the planet
15:25 – 15:30 Conclusions
Full agenda, speakers bios and registration form available on the webpage of the event
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
